Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1993Proceedings of the National Academy of SciencesOpen Access

E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.

View Full Paper
Ask AI
Bookmark
Share

Authors

EFE K FlemingtonHarvard UniversitySSSamuel H. SpeckEmory University
William G. Kaelin
William G. KaelinBroad Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Flemington et al. (1993) studied this question.

synapsesocial.com/papers/6a71d11d8031ec7bb1dd1eefhttps://doi.org/10.1073/pnas.90.15.6914
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of a growth suppression domain within the retinoblastoma gene product.1992 · 411 citations
  2. 2Biological Function of the Retinoblastoma Protein Requires Distinct Domains for Hyperphosphorylation and Transcription Factor Binding1992 · 151 citations
  3. 3Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells1982 · 3,106 citations
  4. 4Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.1982 · 7,748 citations
  5. 5E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins1992 · 1,535 citations